CML is the commonest haematological malignancy encountered in clinical practice; and known for its variability in presentation 1 . Spontaneous hematomas are not a usual presenting symptom of CML 2, 3, 4 . We noted a few reports of CML presenting with intra muscular and neuro-hematomas in the review of literature. We report, spontaneous chest wall hematoma as an uncommon presenting symptom of CML.
axillary area measuring 14x 6 cm (figure-2). Abdominal sonology showed an enlarged spleen and liver, measuring 18 and 3 cm below the costal margin respectively. The bone marrow was hypercellular with erythroid: myeloid ratio of 6:1. Myeloid series were predominantly neutrophil and myelocytes. Erythroid series has normoblastic maturation, megakaryopoisis and lymphoplasmocytes were suppressed. The features were consistent with CML in chronic phase 1 .
The chromosomal study showed BCR-ABL gene positive CML 1, 5 . The chest wall hematoma resolved without any complications over the next 2 weeks. Along with supportive therapy, he was started on hydroxurea for cytoreduction. Later he was started on imitinab and did not develop further spontaneous hematomas or bleeding; and doing well with regular follow-up.
Discussion:
Haematological, bleeding and clotting disorders rank high among the cause for spontaneous hematomas, followed by anti coagulant and anti platelet drugs. 2, 3 Spontaneous hematomas are increasingly encountered in practice, either idiopathic or due to coagulation and bleeding disorders, use of anti coagulant drugs, trauma, secondary malignancies. Spontaneous hematoma is rare and limited to sporadic case reports, associated with neoplasm, aneurysm and arteriovenous malformations. 3 We are reporting the rare initial presentation of CML with spontaneous intra muscular chest wall hematoma.
Chronic myeloid leukemia is a hematopoietic clonal malignant disorder, with an acquired genetic defect in the pluripotential stem cell population. 4 CML has an incidence of 1 to 1.5 per 100,000 per year. The diagnosis is usually made in the relatively indolent chronic phase that remains stable for a number of years till a more aggressive phase. Majority of CML clinically present in the chronic phase of the disease, as seen with our case. In CML prior to its diagnosis, the patients are asymptomatic or they have nonspecific symptoms such as fatigue, fever, bone pain, or weight loss.
In the extensive review of literature, there are two reports of intra muscular hematomas occurring in CML. Kuo YC et al reported a case of CML who presented with mediastinal hematoma and hemothorax. Bauduceau O et al reported a case of spontaneous hematoma of the iliac psoas muscle in CML. 6, 7 There is no mention of any precipitating event prior to development of hematoma. In our case the patient had a trivial strain prior to the development of hematoma. There is a report of gluteal muscle hematoma in a case CML on chemotherapy for cytoreduction. 8 There are few reports of spinal epidural hematomas as the initial presenting feature of CML. 9, 10 Recently, Abdulhamid MM has reported a case of spontaneous acute subdural hematoma as the initial manifestation of chronic myeloid leukemia. 11 The mechanism of spontaneous hematoma in CML is still debated. Specific platelet defects including abnormal platelet morphology, acquired storage pool disease, platelet membrane abnormalities, and abnormal arachidonic acid metabolism were thought to be the reason. 2 It is believed that in CML the platelet dysfunction originated from a clonal expansion of dysfunctional megakaryocytes. These are possibly derived from the identical stem cell from which the CML blasts had originated. Thus the treatment targeting BCR-ABL would be equally effective in reducing the CML blasts and dysfunctional megakaryocytes. This is validated by observation that using tyrosine kinase inhibitors in patients with CML would improve the platelet dysfunction. 5, 8 Further research is required to understand, and would possibly improve the management of platelet dysfunction in CML. 
